Trimspa, Cortislim and Basic Research show leadership in diet supplements.
For companies selling weight-loss supplements in the United States, 2004 was a rollercoaster of a year.
* There was the sharp turn on April 12, 2004, when the FDA’s ban on ephedra swept the last of the formerly top-selling ephedra-based product from store shelves, supplement websites and direct marketers’ sample cases. Most companies selling in the mass market channels had dumped the controversial ingredient at least a year before, while some smaller players stayed in the ephedra business until the end. And as much as the early “ephedrafree” adopters could feel good about their prudence, the size of some of these companies made them targets for ephedra-related lawsuits. On the other side of the coin, some of the ephedra holdouts benefited from extraordinary first quarter sales to consumers who were eager to stock up before the ban went into effect, while their small size made them less of a target for litigation.
* On the heels of the ephedra action, FDA...
Sign in to view
the full article
This article is part of our paid subscription packages. You need to subscribe (and sign in) to gain access to this Subscriber Only Content.
Why Subscribe to Nutrition Business Journal?
- In-depth perspective on the $226 billion global nutrition industry
- Receive monthly issues and access up to 5 years of back issues
- Downloadable data files, presentations, and more